{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:44:54Z","timestamp":1760622294054},"reference-count":29,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":572,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respirology"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:title><jats:bold>Objective<\/jats:bold>:<\/jats:title><jats:p>To assess the change in bronchial response to cumulative doses from two beclomethasone dipropionate metered\u2010dose inhalers (MDI), each using chlorofluorocarbon (CFC) propellants, in asthma patients previously showing falls in forced expiratory volume in 1 s (FEV<jats:sub>1<\/jats:sub>) shortly after exposure to beclomethasone MDI.<\/jats:p><jats:p> <jats:bold>Methodology<\/jats:bold>: A total of 18 patients were randomized to a single\u2010blind, three\u2010period cross\u2010over treatment regimen, whereby each was administered increasing doses of control mixture (containing surfactant and CFC propellants) or beclomethasone, formulated as either Becloforte\u2122 or Respocort\u2122 (250\u20131000 \u03bcg per dose; cumulative dose 2000 \u03bcg). Bronchial response was measured by comparison of FEV<jats:sub>1<\/jats:sub> values pre\u2010 and post\u2010inhalation.<\/jats:p><jats:p> <jats:bold>Results<\/jats:bold>: Respocort formulation produced the least post\u2010dose mean maximum reduction in FEV<jats:sub>1<\/jats:sub> (0.36 \u00b1 0.17 L; 14.3 \u00b1 7.2% of baseline FEV<jats:sub>1<\/jats:sub>), while the reduction caused by the control was similar (0.40 \u00b1 0.18 L; 16.2 \u00b1 9.9% of baseline FEV<jats:sub>1<\/jats:sub>). Becloforte produced a significantly greater maximum reduction in FEV<jats:sub>1<\/jats:sub> than Respocort (0.55 \u00b1 0.32 L, <jats:italic>P<\/jats:italic> = 0.003; 22.0 \u00b1 15.3% of baseline FEV<jats:sub>1<\/jats:sub>, <jats:italic>P<\/jats:italic> = 0.005). No serious adverse events were reported, but four patients experienced falls in FEV<jats:sub>1<\/jats:sub> of greater than 15% (three on Becloforte, one using the control).<\/jats:p><jats:p> <jats:bold>Conclusion<\/jats:bold>: The incidence of falls in FEV<jats:sub>1<\/jats:sub> following use of beclomethasone MDI was low and generally not serious even in a selected population. The Becloforte preparation produced significantly more post\u2010dose bronchoconstriction than the Respocort formulation, perhaps because of differences in the composition of the surfactant and\/or CFC propellant mixtures used to formulate each of the aerosols.<\/jats:p>","DOI":"10.1046\/j.1440-1843.2000.00238.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T19:20:05Z","timestamp":1047496805000},"page":"125-131","source":"Crossref","is-referenced-by-count":5,"title":["Post\u2010inhalation bronchoconstriction by beclomethasone dipropionate: A comparison of two different CFC propellant formulations in asthmatics"],"prefix":"10.1111","volume":"5","author":[{"given":"Richard E.","family":"Ruffin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald A.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mon M.","family":"Chia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"247","article-title":"Severe bronchoconstriction after inhalation of beclomethasone and budesonide.","volume":"27","author":"Poh SC","year":"1986","journal-title":"Sing. Med. J."},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.91.2.207"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1993.tb138031.x"},{"key":"e_1_2_7_5_2","first-page":"187","article-title":"Should bronchodilators be given routinely before aerosol steroids? A review of current approaches.","volume":"23","author":"Eckert B","year":"1993","journal-title":"Aust. J. Hosp. Pharm."},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.94.07122160"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/02770909109073370"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6859.931"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.2.512"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/jam.1991.4.163"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.24.2.228"},{"key":"e_1_2_7_12_2","first-page":"494","article-title":"Deep\u2010inspiration induced bronchoconstriction: A mechanism for beclomethasone aerosol intolerance.","volume":"64","author":"Charpin D","year":"1983","journal-title":"Eur. J. Respir. Dis."},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.34.2.234"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.289.6443.469"},{"key":"e_1_2_7_15_2","volume-title":"Aerosols in Medicine: Principles, Diagnosis and Therapy.","author":"Moren F","year":"1985"},{"key":"e_1_2_7_16_2","volume-title":"The Design and Analysis of Clinical Experiments.","author":"Fliess J.","year":"1986"},{"key":"e_1_2_7_17_2","volume-title":"Applied Linear Statistical Models.","author":"Neter J","year":"1985"},{"key":"e_1_2_7_18_2","volume-title":"Nonparametric Statistical Methods.","author":"Hollander M","year":"1973"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03259410"},{"key":"e_1_2_7_20_2","first-page":"268","article-title":"Severe bronchoconstriction after inhalation of budesonide.","volume":"288","author":"McGivern D","year":"1989","journal-title":"BMJ"},{"key":"e_1_2_7_21_2","first-page":"433","article-title":"Bronchoconstrictor effects of a deep inspiration in patients with asthma.","volume":"111","author":"Gayrard P","year":"1975","journal-title":"Am. Rev. Resp. Dis."},{"key":"e_1_2_7_22_2","first-page":"25","article-title":"Metered dose inhaler induced bronchospasm in asthmatic patients.","volume":"55","author":"Yarbrough J","year":"1985","journal-title":"Ann. Allergy"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(91)90025-J"},{"key":"e_1_2_7_24_2","unstructured":"BryantDH&PepysJ.Bronchial reactions to aerosol inhalant vehicle.BMJ1976;131920."},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1979.tb00483.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)92246-4"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.294.6581.1197-a"},{"key":"e_1_2_7_28_2","unstructured":"AhmadD.Effects of aerosol propellants on airways function in metered dose inhalers.In: SW Epstein (ed.).Astra Pharmaceuticals Canada 1984:226."},{"key":"e_1_2_7_29_2","first-page":"363","article-title":"Immediate bronchoconstriction response to metered dose albuterol. (Abstract 5).","volume":"50","author":"Yarbrough J","year":"1983","journal-title":"Ann. Allergy"},{"key":"e_1_2_7_30_2","first-page":"2892","article-title":"Side\u2010effects of aerosol therapy with freon dispersal in patients with asthma and cystic fibrosis.","volume":"141","author":"M\u00f8ller NE","year":"1979","journal-title":"Ugeskr. L\u00e6g."}],"container-title":["Respirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-1843.2000.00238.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-1843.2000.00238.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1440-1843.2000.00238.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-1843.2000.00238.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T11:01:45Z","timestamp":1694430105000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-1843.2000.00238.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1046\/j.1440-1843.2000.00238.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-1843.2000.00238.x","archive":["Portico"],"relation":{},"ISSN":["1323-7799","1440-1843"],"issn-type":[{"value":"1323-7799","type":"print"},{"value":"1440-1843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}